About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
+13 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Technicals
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Profit & Loss
Caplin Point Laboratories Ltd
Pharmaceuticals - Indian - Formulations
BSE Code:
524742
NSE Symbol:
CAPLIPOINT
P/E :
47.93
ISIN Demat:
INE475E01026
Div & Yield %:
0.26
EPS :
44.66
Book Value:
223.77
Market Cap (Rs. Cr.):
16,269.54
Face Value :
2
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
INCOME :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Sales Turnover
625.09
528.61
528.06
482.68
527.83
536.91
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
625.09
528.61
528.06
482.68
527.83
536.91
Other Income
105.84
99.00
56.55
18.62
65.97
35.40
Stock Adjustments
43.68
1.67
9.00
0.57
0.74
2.51
Total Income
774.61
629.28
593.61
501.87
594.54
574.82
EXPENDITURE :
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
₹
Cr
Raw Materials
248.90
199.73
213.65
195.40
238.92
239.54
Power & Fuel Cost
15.43
9.89
9.54
6.36
7.19
12.29
Employee Cost
38.11
36.68
30.47
26.59
25.00
42.01
Other Manufacturing Expenses
25.43
13.73
10.81
7.75
8.98
15.56
Selling & Administrative Expenses
39.86
40.30
43.51
28.12
38.19
39.24
Miscellaneous Expenses
13.96
10.03
9.46
5.10
3.29
2.17
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
381.69
310.36
317.44
269.32
321.57
350.82
Operating Profit
392.92
318.92
276.17
232.55
272.97
224.00
Interest
0.10
0.12
0.09
0.17
0.19
0.50
Gross Profit
392.82
318.80
276.08
232.38
272.78
223.50
Depreciation
27.08
25.65
25.77
22.44
19.65
20.84
Profit Before Tax
365.74
293.15
250.31
209.94
253.13
202.66
Tax
86.12
66.58
61.62
54.88
55.89
54.11
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
-4.09
-7.69
0.82
-1.17
-0.40
0.38
Reported Net Profit
283.71
234.26
187.87
156.23
197.64
148.17
Extraordinary Items
1.19
1.17
0.75
4.67
3.75
1.32
Adjusted Net Profit
282.52
233.09
187.12
151.56
193.89
146.85
Adjustment below Net Profit
0.00
0.00
0.00
0.00
0.00
0.00
P & L Balance brought forward
1,083.95
880.01
714.84
561.64
396.53
263.48
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
34.17
30.32
22.70
3.03
32.53
15.12
P & L Balance carried down
1,333.49
1,083.95
880.01
714.84
561.64
396.53
Dividend
15.19
15.16
11.35
0.00
15.88
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
250.00
225.00
200.00
150.00
125.00
110.00
Dividend Per Share(Rs)
5.00
4.50
4.00
3.00
2.50
2.20
Earnings Per Share-Unit Curr
37.35
30.86
24.78
20.65
26.13
19.59
Earnings Per Share(Adj)-Unit Curr
37.35
30.86
24.78
20.65
26.13
19.59
Book Value-Unit Curr
183.03
150.19
122.78
100.29
79.31
57.13
Book Value(Adj)-Unit Curr
183.03
150.19
122.78
100.29
79.31
57.13